ENTA Prakiraan wutah bathi resik saben saham kanggo taun ngarep Enanta Pharmaceuticals, Inc.

Simbol lan logo merek Enanta Pharmaceuticals (ENTA)

Enanta Pharmaceuticals (ENTA) is characterized by a transparent R&D pipeline and strict cost control. The GURU.Markets portal contains the history of changes in earnings per share expectations, where 4.20 reflects the baseline level of the metric. High barriers to entry create unique patent protections, while future revenues rely on the success of new developments and current royalties from hepatitis C treatment.

ENTA: Prakiraan wutah bathi resik saben saham ing taun ngarep Enanta 04.07.2022 - 16.11.2026

Rincian analitis lan laporan data perusahaan Enanta Pharmaceuticals Inc. (ENTA)

Analisis umum perusahaan:Enanta
Produk dadi Enanta Pharmaceuticals, Inc.

This indicator is critical for filtering assets and stress-testing a portfolio for future returns. It captures the consensus forecast for earnings per share (EPS) changes, stripping analyst expectations of market noise and emotional volatility. The trend in projected EPS changes for the coming year reflects a fundamental revaluation of the business. For Enanta Pharmaceuticals (ENTA), this directly correlates with progress in developing protease inhibitors for the therapy of respiratory viruses.

Pesaing langsung

Prakiraan wutah bathi saben saham kanggo taun ngarep GILD|Prakiraan wutah bathi kanggo taun ngarep Cidara Therapeutics, Inc.|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Novavax Inc (NVAX)|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep CureVac|Valneva Pharma - Prakiraan wutah bathi saben saham kanggo taun ngarep|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Vir Corp (VIR)|siga.com - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep emergentbiosolutions.com|AVIR: Prakiraan wutah bathi kanggo taun ngarep|IVVD (Invivyd Inc) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|INO (Inovio Pharma) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep HLVX|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Kalaris Therapeutics Inc (KLRS)|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Dyadic International, Inc.|Prakiraan wutah bathi kanggo taun ngarep NNVC (nanoviricides.com)|Talphera Inc (TLPH) - Prakiraan wutah bathi resik saben saham ing taun ngarep|COCP: Prakiraan wutah bathi saben saham kanggo taun ngarep|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep TRAW|DWTX (Virios Therapeutics) - Prakiraan wutah bathi saben saham kanggo taun ngarep|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep QLGN|ALVR (AlloVir) - Prakiraan wutah bathi kanggo taun ngarep|vbivaccines.com (VBIV) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep VIRI|Prakiraan wutah bathi saben saham kanggo taun ngarep Vaxart Corp VXRT